Unfolding the role of protein misfolding in neurodegenerative diseases
The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neurodegenerative diseases, such as AD and DLB, are often characterized as diseases of protein aggregation (30–33).”
From APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia (2021) · cites this paper as [30]
In the citing paper
“Importantly, most of these age-related primary neurodegenerative diseases involve disorders of protein processing and aggregation.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
In the citing paper
“The hallmark feature of these proteinopathies are the fibrillary aggregates of misfolded or hyperphosphorylated proteins (59).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [59]
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundRosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundGlenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundWalsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMcKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundDiffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 1×
“The first are soluble, low-molecular-weight oligomers (dimers to decamers), which have been found in test-tube experiments, in the conditioned medium of cells that constitutively secrete Aβ, in human cerebrospinal fluid and in human brain homogenat”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundShah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundAggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundInherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434 · cited 1×
“There is also evidence that β-sheet oligomerization of non-disease-related proteins is cytotoxic, indicating that misfolding and aggregation of any protein results in inherent toxicit”
BackgroundPan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., & Cohen, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.10962 · Cited by 2,277
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Protein misfolding, evolution and disease
Dobson, C. M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01445-0 · Cited by 1,952 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMicrotubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,778 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMasliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. Cohen
Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., & Blake, C. C. F. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1348 · Cited by 1,707 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundNormal development and behaviour of mice lacking the neuronal cell-surface PrP protein
Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M., & Weissmann, C. (1992) · Nature · doi:10.1038/356577a0 · Cited by 1,655
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605
Saudou, F., Finkbeiner, S., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,595 · cited 1×
“Finally, although in most studies inhibitors of protein aggregation also prevent neuronal damage, some in vitro and in vivo studies found that, under certain conditions, prevention of aggregation did not inhibit (or even increased) cell deat”
BackgroundConway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480 · cited 1×
“This fragment contains the hydrophobic non-amyloid component peptide that was previously identified as a component of AD amyloid-like plaques by Saitoh and co-workers and was shown to be amyloidogeni”
BackgroundNeuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465 · cited 1×
“In patients with PD, the cytoplasm of neurons from the substantia nigra contains aggregates called Lewy bodie”
BackgroundCherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 1×
“Strategies for the specific removal of amyloid-P components, proteoglycans and metal ions have shown the best results in models of AD and systemic amyloidosi”
BackgroundAβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431 · cited 1×
“and improvement of behavioural and cognitive impairments in animal model”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Glutamine Repeats and Neurodegeneration
Zoghbi, H. Y., & Orr, H. T. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.217 · Cited by 1,309 · cited 1×
“In HD, SCA and other polyglutamine diseases, both disease and protein aggregation are associated with an inherited expansion of CAG (the codon for glutamine) repeat”
BackgroundReaume, A. G., Elliott, J. L., Hoffman, E. K., Kowall, N. W., Ferrante, R. J., Siwek, D. R., Wilcox, H. M., Flood, D. G., Beal, M. F., Brown, R. H., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-43 · Cited by 1,292 · cited 1×
“However, SOD1 knockout mice show no degeneration of motor neuron”
BackgroundScherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291 · cited 1×
“Aggregation of huntingtin in vitro depends on the length of the polyglutamine repea”
BackgroundMCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“In this hypothesis, abnormal protein aggregates act as irritants and cause a chronic inflammatory reaction in the brain that leads to neuronal death and synaptic change”
BackgroundIdentification of a Protein That Purifies with the Scrapie Prion
Bolton, D. C., McKinley, M. P., & Prusiner, S. B. (1982) · Science · doi:10.1126/science.6815801 · Cited by 1,280 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundInflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1
Bruijn, L. I., Houseweart, M. K., Kato, S., Anderson, K. L., Anderson, S. D., Ohama, E., Reaume, A. G., Scott, R. W., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.281.5384.1851 · Cited by 1,228 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundKatzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988) · Annals of Neurology · doi:10.1002/ana.410230206 · Cited by 1,225 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
Background[URE3] as an Altered URE2 Protein: Evidence for a Prion Analog in Saccharomyces cerevisiae
Wickner, R. B. (1994) · Science · doi:10.1126/science.7909170 · Cited by 1,209 · cited 1×
“pl?Q8NKJ9">Rnq1 can adopt alternative conformations with different activities, and the misfolded protein aggregates can convert the monomeric folded proteins in vitro and in vivo”
BackgroundAmyloid β-Protein Fibrillogenesis
Walsh, D. M., Lomakin, A., Benedek, G. B., Condron, M. M., & Teplow, D. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22364 · Cited by 1,145 · cited 1×
“The second intermediates are short, flexible, rod-like structures termed protofibrils, which have been studied by electron microscopy, photon correlation spectroscopy and atomic force microscop”
BackgroundReversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease
Yamamoto, A., Lucas, J. J., & Hen, R. (2000) · Cell · doi:10.1016/s0092-8674(00)80623-6 · Cited by 1,067 · cited 1×
“In a conditional transgenic model of HD, preventing the production of mutant fragments caused nuclear inclusions to disappear, indicating that cells can metabolize the aggregated materia”
BackgroundGlutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.
Perutz, M. F., Johnson, T., Suzuki, M., & Finch, J. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5355 · Cited by 1,062
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons.
Loo, D. T., Copani, A., Pike, C. J., Whittemore, E. R., Walencewicz, A. J., & Cotman, C. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7951 · Cited by 1,030
Ataxin-1 Nuclear Localization and Aggregation
Klement, I. A., Skinner, P. J., Kaytor, M. D., Yi, H., Hersch, S. M., Clark, H. B., Zoghbi, H. Y., & Orr, H. T. (1998) · Cell · doi:10.1016/s0092-8674(00)81781-x · Cited by 956 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundNeurotoxicity of a prion protein fragment
Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., & Tagliavini, F. (1993) · Nature · doi:10.1038/362543a0 · Cited by 943
Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940 · cited 1×
“Evidence that there is a chronic inflammatory reaction in the brain for most of the neurodegenerative diseases includes: extensive astrocytosis and microglial activation in patients, especially around protein deposit”
BackgroundArispe, N., Rojas, E., & Pollard, H. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.567 · Cited by 926
Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology
Gutekunst, C.-A., Li, S.-H., Yi, H., Mulroy, J. S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R. J., Hersch, S. M., & Li, X.-J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02522.1999 · Cited by 914 · cited 1×
“Post-mortem studies that show a poor correlation between the load of amyloid-like deposits in the brain and the severity of clinical symptom”
BackgroundSoto, C., Sigurdsson, E. M., Morelli, L., Asok Kumar, R., Castaño, E. M., & Frangione, B. (1998) · Nature Medicine · doi:10.1038/nm0798-822 · Cited by 876
Self-citationLinkage of a prion protein missense variant to Gerstmann–Sträussler syndrome
Hsiao, K., Baker, H. F., Crow, T. J., Poulter, M., Owen, F., Terwilliger, J. D., Westaway, D., Ott, J., & Prusiner, S. B. (1989) · Nature · doi:10.1038/338342a0 · Cited by 849 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundHartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817
Carrell, R. W., & Lomas, D. A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02073-4 · Cited by 807
Amyloid fibrils from muscle myoglobin
Fändrich, M., Fletcher, M. A., & Dobson, C. M. (2001) · Nature · doi:10.1038/35065514 · Cited by 799 · cited 1×
“However, recent studies have shown that many (if not all) proteins can form amyloid-like structures under appropriate condition”
BackgroundConway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786 · cited 1×
“Low-resolution structural studies have shown, in all cases, a large secondary structural difference between the monomeric native protein and the aggregated materia”
BackgroundFiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
Serpell, L. C., Berriman, J., Jakes, R., Goedert, M., & Crowther, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4897 · Cited by 748
Cummings, C. J., Mancini, M. A., Antalffy, B., DeFranco, D. B., Orr, H. T., & Zoghbi, H. Y. (1998) · Nature Genetics · doi:10.1038/502 · Cited by 744
Bush, A. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00073-3 · Cited by 731 · cited 1×
“Several of the proteins implicated in misfolding (including PrP, SOD1 and Aβ) can bind metal ions, indicating that a common mechanism of neurodegeneration might involve changes in metal ion homeostasi”
Backgroundα-Synuclein Fibrillogenesis Is Nucleation-dependent
Wood, S. J., Wypych, J., Steavenson, S., Louis, J.-C., Citron, M., & Biere, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19509 · Cited by 720 · cited 1×
“Kinetic studies have shown that the aggregation of Aβ, PrP, huntingtin, α-synuclein and other proteins involved in systemic amyloidosis follows a seeding/nucleation mechanis”
Backgroundα-Synuclein Promotes Mitochondrial Deficit and Oxidative Stress
Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M., Wong, J., Takenouchi, T., Hashimoto, M., & Masliah, E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64553-1 · Cited by 714 · cited 1×
“Finally, protein aggregates might induce OXIDATIVE STRESS by producing free radical species, resulting in protein and lipid oxidation, elevation of intracellular calcium and mitochondrial disfunctio”
BackgroundScherzinger, E., Sittler, A., Schweiger, K., Heiser, V., Lurz, R., Hasenbank, R., Bates, G. P., Lehrach, H., & Wanker, E. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4604 · Cited by 705 · cited 1×
“Kinetic studies have shown that the aggregation of Aβ, PrP, huntingtin, α-synuclein and other proteins involved in systemic amyloidosis follows a seeding/nucleation mechanis”
BackgroundMoechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundImmunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) · PubMed · Cited by 660
Electron Microscopic Observations on a Fibrous Component in Amyloid of Diverse Origins
COHEN, A. S., & CALKINS, E. (1959) · Nature · doi:10.1038/1831202a0 · Cited by 638 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundBarrow, C. J., Yasuda, A., Kenny, P. T. M., & Zagorski, M. G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90106-t · Cited by 635 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundWater-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618
Dragatsis, I., Levine, M. S., & Zeitlin, S. (2000) · Nature Genetics · doi:10.1038/81593 · Cited by 576
Early and Progressive Accumulation of Reactive Microglia in the Huntington Disease Brain
Sapp, E., Kegel, K. B., Aronin, N., Hashikawa, T., Uchiyama, Y., Tohyama, K., Bhide, P. G., Vonsattel, J. P., & Difiglia, M. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.2.161 · Cited by 540
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., Gallimore, J. R., Lovat, L. B., Bartfai, T., Alanine, A., Hertel, C., et al. (2002) · Nature · doi:10.1038/417254a · Cited by 540
Spontaneous Neurodegeneration in Transgenic Mice with Mutant Prion Protein
Hsiao, K. K., Scott, M., Foster, D., Groth, D. F., DeArmond, S. J., & Prusiner, S. B. (1990) · Science · doi:10.1126/science.1980379 · Cited by 530 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundIs there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson’s disease?
Goldberg, M. S., & Lansbury Jr, P. T. (2000) · Nature Cell Biology · doi:10.1038/35017124 · Cited by 458
Harper, J. D., Wong, S. S., Lieber, C. M., & Lansbury, P. T. (1999) · Biochemistry · doi:10.1021/bi9904149 · Cited by 454
Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice
Wyss-Coray, T., Yan, F., Lin, A. H.-T., Lambris, J. D., Alexander, J. J., Quigg, R. J., & Masliah, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162350199 · Cited by 446 · cited 1×
“Inhibiting the activation of the C3 complement component increased neurodegeneration and plaque load in transgenic animal models of A”
BackgroundPrions prevent neuronal cell-line death
Kuwahara, C., Takeuchi, A. M., Nishimura, T., Haraguchi, K., Kubosaki, A., Matsumoto, Y., Saeki, K., Matsumoto, Y., Yokoyama, T., Itohara, S., et al. (1999) · Nature · doi:10.1038/22241 · Cited by 441 · cited 1×
“In addition, PrP-null neuronal cell lines are more susceptible to serum deprivation-induced apoptosis, and overexpression of the anti-apoptotic protein Bcl2 (B-cell leukaemia/lymphoma 2) can attenuate this sensitivit”
BackgroundAmyloid-β immunotherapy for Alzheimer's disease: the end of the beginning
Schenk, D. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn938 · Cited by 436
Molecular Basis of the Neurodegenerative Disorders
Martin, J. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402507 · Cited by 418 · cited 1×
“Neurodegenerative diseases can affect abstract thinking, skilled movements, emotional feelings, cognition, memory and other abilitie”
BackgroundHilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90835-8 · Cited by 413 · cited 1×
“Peptides containing the 40- or 42-residue forms of Aβ, and shorter derivatives, form amyloid-like fibrils in vitro , which are morphologically, tinctorially, immunologically, spectroscopically and ultrastructurally similar to fibrillar aggregates extracted from AD amyloid plaque”
BackgroundKane, M. D., Lipinski, W. J., Callahan, M. J., Bian, F., Durham, R. A., Schwarz, R. D., Roher, A. E., & Walker, L. C. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03606.2000 · Cited by 394 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundMallucci, G. R., Ratté, S., Asante, E. A., Linehan, J., Gowland, I., Jefferys, J. G. R., & Collinge, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.202 · Cited by 393 · cited 1×
“A recent study showed that post-natal PrP knockout mice remained healthy, without evidence of neurodegeneration or other histopathological changes, for up to 15 months after the knockout, diminishing the likelihood that loss of PrP function cause TSE”
BackgroundPrion Protein Protects Human Neurons against Bax-mediated Apoptosis
Bounhar, Y., Zhang, Y., Goodyer, C. G., & LeBlanc, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100443200 · Cited by 385 · cited 1×
“Moreover, PrP C can protect human neurons against Bax-induced apoptosi”
BackgroundLoss of normal huntingtin function: new developments in Huntington's disease research
Cattaneo, E. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01721-5 · Cited by 382 · cited 1×
“In HD, the fact that homozygous knockout mice for huntingtin die early in embryonic development has been used as evidence for the loss-of-function hypothesi”
BackgroundCellular prion protein transduces neuroprotective signals
Chiarini, L. B. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf324 · Cited by 376 · cited 1×
“In vitro , ligand-activation of PrP C leads to a neuroprotective signa”
BackgroundDePace, A. H., Santoso, A., Hillner, P., & Weissman, J. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81467-1 · Cited by 364 · cited 1×
“The aggregation of the yeast prions seems to follow the same principl”
BackgroundKisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., & Szarek, W. A. (1995) · Nature Medicine · doi:10.1038/nm0295-143 · Cited by 363 · cited 1×
“Strategies for the specific removal of amyloid-P components, proteoglycans and metal ions have shown the best results in models of AD and systemic amyloidosi”
BackgroundEl-Agnaf, O. M. A., Jakes, R., Curran, M. D., Middleton, D., Ingenito, R., Bianchi, E., Pessi, A., Neill, D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01418-5 · Cited by 363
Watase, K., Weeber, E. J., Xu, B., Antalffy, B., Yuva-Paylor, L., Hashimoto, K., Kano, M., Atkinson, R., Sun, Y., Armstrong, D. L., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)00733-x · Cited by 359 · cited 1×
“pl?P54254">ataxin-1 protein contains extra glutamine repeats show many clinical and pathological signs similar to SCA type 1, including loss of motor coordination and Purkinje cell degeneratio”
BackgroundAmyloid-like Features of Polyglutamine Aggregates and Their Assembly Kinetics
Chen, S., Berthelier, V., Hamilton, J. B., O'Nuallai, B., & Wetzel, R. (2002) · Biochemistry · doi:10.1021/bi011772q · Cited by 348 · cited 1×
“Low-resolution structural studies have shown, in all cases, a large secondary structural difference between the monomeric native protein and the aggregated materia”
BackgroundInhibiting transthyretin amyloid fibril formation via protein stabilization
Miroy, G. J., Lai, Z., Lashuel, H. A., Peterson, S. A., Strang, C., & Kelly, J. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15051 · Cited by 344 · cited 1×
“pl?P07309">transthyretin (a protein that has been implicated in systemic amyloid disorders”
BackgroundReceptor-dependent cell stress and amyloid accumulation in systemic amyloidosis
Yan, S. D., Zhu, H., Zhu, A., Golabek, A., Du, H., Roher, A., Yu, J., Soto, C., Schmidt, A. M., Stern, D., et al. (2000) · Nature Medicine · doi:10.1038/76216 · Cited by 343
Self-citationGenetic Classification of Primary Neurodegenerative Disease
Hardy, J., & Gwinn-Hardy, K. (1998) · Science · doi:10.1126/science.282.5391.1075 · Cited by 343 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundProtein misfolding and disease; protein refolding and therapy
Soto, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02486-3 · Cited by 336 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundSelf-citationSoto, C., Castaño, E. M., Frangione, B., & Inestrosa, N. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3063 · Cited by 321
Self-citationProlines and Aamyloidogenicity in Fragments of the Alzheimer's Peptide .beta./A4
Wood, S. J., Wetzel, R., Martin, J. D., & Hurle, M. R. (1995) · Biochemistry · doi:10.1021/bi00003a003 · Cited by 312
Polyglutamine protein aggregates are dynamic
Kim, S., Nollen, E. A. A., Kitagawa, K., Bindokas, V. P., & Morimoto, R. I. (2002) · Nature Cell Biology · doi:10.1038/ncb863 · Cited by 298 · cited 1×
“In addition, the concept that protein deposits are static and irreversible structures has been changing to accommodate recent results showing that the protein component of aggregates, as well as the associated proteins, are in dynamic equilibrium with the soluble versions of the protein”
BackgroundChemical chaperones interfere with the formation of scrapie prion protein.
Tatzelt, J., Prusiner, S. B., & Welch, W. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01027.x · Cited by 294
Trans -Suppression of Misfolding in an Amyloid Disease
Hammarström, P., Schneider, F., & Kelly, J. W. (2001) · Science · doi:10.1126/science.1062245 · Cited by 293
Structural and kinetic features of amyloid β-protein fibrillogenesis: Review
Teplow, D. B. (1998) · Amyloid · doi:10.3109/13506129808995290 · Cited by 283
Microtubule-Associated Protein Tau
Yen, S.-H., Nacharaju, P., Ko, L.-W., Kenessey, A., & Liu, W.-K. (1998) · Handbook of the Aging Brain · doi:10.1016/b978-012734610-6/50012-9 · Cited by 282
Transmissibility of systemic amyloidosis by a prion-like mechanism
Lundmark, K., Westermark, G. T., Nyström, S., Murphy, C. L., Solomon, A., & Westermark, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092205999 · Cited by 278 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundHYMAN, B. T., MARZLOFF, K., & ARRIAGADA, P. V. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199311000-00006 · Cited by 276
Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides
Soto, C., Kascsak, R. J., Saborío, G. P., Aucouturier, P., Wisniewski, T., Prelli, F., Kascsak, R., Mendez, E., Harris, D. A., Ironside, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11419-3 · Cited by 274
Self-citationChemokines/chemokine receptors in the central nervous system and Alzheimer's disease
Xia, M., & Hyman, B. T. (1999) · Journal of Neurovirology · doi:10.3109/13550289909029743 · Cited by 269 · cited 1×
“; increased levels of inflammatory proteins such as cytokines, chemokines and growth factors in the brai”
BackgroundTherapeutic strategies for human amyloid diseases
Sacchettini, J. C., & Kelly, J. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd769 · Cited by 261 · cited 1×
“pl?P09813">apolipoprotein E , amyloid P-component and proteoglycans) have been reported to prevent protein aggregatio”
BackgroundThe C‐Terminus of the β Protein is Critical in Amyloidogenesisa
JARRETT, J. T., BERGER, E. P., & LANSBURY, P. T. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23043.x · Cited by 260
Prions as Protein-Based Genetic Elements
Uptain, S. M., & Lindquist, S. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.013002.100603 · Cited by 244 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundAnti‐amyloidogenic activity of tetracyclines: studies in vitro
Forloni, G., Colombo, L., Girola, L., Tagliavini, F., & Salmona, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02380-2 · Cited by 242 · cited 1×
“IDOX (4′-iodo-4′-deoxydoxorubicin) and tetracycline have also been reported to inhibit protein misfolding and to dissolve pre-formed aggregates of several protein”
BackgroundSynthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro.
Tagliavini, F., Prelli, F., Verga, L., Giaccone, G., Sarma, R., Gorevic, P., Ghetti, B., Passerini, F., Ghibaudi, E., & Forloni, G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9678 · Cited by 242 · cited 1×
“Similar studies of PrP misfolding have identified the hydrophobic fragment 106–126 as the most relevant for protein aggregatio”
BackgroundDecreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus
Myers, R. H., Vonsattel, J. P., Paskevich, P. A., Kiely, D. K., Stevens, T. J., Cupples, L. A., Richardson, E. P., & Bird, E. D. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00005 · Cited by 239 · cited 1×
“In HD, there is severe neuronal loss initially in the neostriatum and later in the cerebral corte”
BackgroundAging-associated Changes in Human Brain
MRAK, R. E., T. GRIFFIN, W. S., & GRAHAM, D. I. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199712000-00001 · Cited by 228 · cited 1×
“Many of these alterations are associated with ageing, consistent with the late onset of neurodegenerative disease”
Castaño, E. M., Ghiso, J., Prelli, F., Gorevic, P. D., Migheli, A., & Frangione, B. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80241-8 · Cited by 225 · cited 1×
“Peptides containing the 40- or 42-residue forms of Aβ, and shorter derivatives, form amyloid-like fibrils in vitro , which are morphologically, tinctorially, immunologically, spectroscopically and ultrastructurally similar to fibrillar aggregates extracted from AD amyloid plaque”
BackgroundNicotine Inhibits Amyloid Formation by the β-Peptide
Salomon, A. R., Marcinowski, K. J., Friedland, R. P., & Zagorski, M. G. (1996) · Biochemistry · doi:10.1021/bi9617264 · Cited by 220
Permanne, B., Adessi, C., Saborio, G. P., Fraga, S., Frossard, M., Van Dorpe, J., Dewachter, I., Banks, W. A., Van Leuven, F., & Soto, C. (2002) · The FASEB Journal · doi:10.1096/fj.01-0841fje · Cited by 220
Self-citationIi, K., ITO, H., TANAKA, K., & HIRANO, A. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00002 · Cited by 215
da Costa, C. A., Ancolio, K., & Checler, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002413200 · Cited by 213
Pathology of amyotrophic lateral sclerosis.
Jt, H. (1982) · PubMed · Cited by 209
Merlini, G., Ascari, E., Amboldi, N., Bellotti, V, Arbustini, E., Perfetti, V, Ferrari, M., Zorzoli, I., Marinone, M. G., & Garini, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2959 · Cited by 205
Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202 · cited 1×
“; in vitro studies showing that misfolded and aggregated proteins can activate microglia and astrocytes, inducing them to release inflammatory protein”
BackgroundImmunization Delays the Onset of Prion Disease in Mice
Sigurdsson, E. M., Brown, D. R., Daniels, M., Kascsak, R. J., Kascsak, R., Carp, R., Meeker, H. C., Frangione, B., & Wisniewski, T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64151-x · Cited by 190 · cited 1×
“A similar approach has been used for the treatment of TS”
MethodChannel Formation by a Neurotoxic Prion Protein Fragment
Lin, M.-C., Mirzabekov, T., & Kagan, B. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.44 · Cited by 190 · cited 1×
“Another proposed mechanism for Aβ and PrP neurotoxicity is membrane disruption and depolarization mediated by ion-channel formation, resulting in alteration of ion homeostasis and disregulation of cellular signal transduction, leading to cell deat”
BackgroundA cellular model that recapitulates major pathogenic steps of Huntington's disease
Lunkes, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.9.1355 · Cited by 189
Molecular Structure of a Fibrillar Alzheimer's Aβ Fragment
Serpell, L. C., Blake, C., & Fraser, P. E. (2000) · Biochemistry · doi:10.1021/bi000637v · Cited by 185 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundContribution of somal Lewy bodies to neuronal death
Tompkins, M. M., & Hill, W. D. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00874-3 · Cited by 183 · cited 1×
“Neuropathological analysis of the brains of people affected by PD or AD have shown that neurons containing Lewy bodies or neurofibrillary tangles seem to be healthier, by morphological and biochemical analysis, than neighbouring cell”
BackgroundThe cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system
Kurschner, C., & Morgan, J. I. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00013-i · Cited by 176
Neuronal Apoptosis in Creutzfeldt-Jakob Disease
Gray, F., Chrétien, F., Adle-Biassette, H., Dorandeu, A., Ereau, T., Delisle, M.-B., Kopp, N., Ironside, J. W., & Vital, C. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199904000-00002 · Cited by 171 · cited 1×
“In TSEs, the location and extent of neuronal loss var”
BackgroundDominant-negative inhibition of prion replication in transgenic mice
Perrier, V., Kaneko, K., Safar, J., Vergara, J., Tremblay, P., DeArmond, S. J., Cohen, F. E., Prusiner, S. B., & Wallace, A. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182425299 · Cited by 157 · cited 1×
“The same concept has been applied to prevent prion replication in transgenic mic”
BackgroundBorchelt, D. R., Guarnieri, M., Wong, P. C., Lee, M. K., Slunt, H. S., Xu, Z.-S., Sisodia, S. S., Price, D. L., & Cleveland, D. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3234 · Cited by 151
Cellular prion protein: on the road for functions
Martins, V. R., Linden, R., Prado, M. A. M., Walz, R., Sakamoto, A. C., Izquierdo, I., & Brentani, R. R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02291-3 · Cited by 137 · cited 1×
“PrP C has been indicated to be involved in signal transduction, as it is found in caveolae-like domains and interacts with several intracellular signalling protein”
BackgroundNeurofibrillary degeneration and neuronal loss in alzheimer's disease
Bondareff, W., Mountjoy, C. Q., Roth, M., & Hauser, D. L. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90007-9 · Cited by 124 · cited 1×
“Neuropathological analysis of the brains of people affected by PD or AD have shown that neurons containing Lewy bodies or neurofibrillary tangles seem to be healthier, by morphological and biochemical analysis, than neighbouring cell”
BackgroundAmyloid fibril formation by a helical cytochrome
Pertinhez, T., Bouchard, M., Tomlinson, E. J., Wain, R., Ferguson, S. J., Dobson, C. M., & Smith, L. J. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02384-5 · Cited by 122 · cited 1×
“However, recent studies have shown that many (if not all) proteins can form amyloid-like structures under appropriate condition”
Backgroundα-Helix Structure in Alzheimer's Disease Aggregates of Tau-Protein
Sadqi, M., Hernández, F., Pan, U., Pérez, M., Schaeberle, M. D., Ávila, J., & Muñoz, V. (2002) · Biochemistry · doi:10.1021/bi025777e · Cited by 117 · cited 1×
“An exception appears to be the structure of tau aggregates, which is composed mainly of α-helices, as shown by studies using circular dichroism and fourier-transformed infrared spectroscop”
BackgroundMicroglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines
Peyrin, J., Lasmézas, C. I., Haı̈k, S., Tagliavini, F., Salmona, M., Williams, A., Richie, D., Deslys, J., & Dormont, D. (1999) · Neuroreport · doi:10.1097/00001756-199903170-00012 · Cited by 115 · cited 1×
“; in vitro studies showing that misfolded and aggregated proteins can activate microglia and astrocytes, inducing them to release inflammatory protein”
BackgroundProtein engineering as a strategy to avoid formation of amyloid fibrils
Villegas, S., Zurdo, J., Filimonov, V. V., Avilés, F. X., Dobson, C. M., & Serrano, L. (2000) · Protein Science · doi:10.1110/ps.9.9.1700 · Cited by 113 · cited 1×
“Protein engineering has been proposed as an approach to create sequence-modified proteins with higher stability, lower tendency to misfold and the ability to trans-suppress the aggregation of wild-type protein”
BackgroundSoluble multimeric Alzheimer β(1–40) pre-amyloid complexes in dilute solution
LeVine, H. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00052-g · Cited by 113
Protein Misfolding and Disease
Bross, P., & Gregersen, N. (2003) · Humana Press eBooks · doi:10.1385/1592593941 · Cited by 113
Transmission of Mouse Senile Amyloidosis
Xing, Y., Nakamura, A., Chiba, T., Kogishi, K., Matsushita, T., Li, F., Guo, Z., Hosokawa, M., Mori, M., & Higuchi, K. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780257 · Cited by 106 · cited 1×
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
Background[20] Analysis of circular dichroism spectra
Johnson, W. C. (1992) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(92)10022-6 · Cited by 98
Reactive microgIia in Creutzfeldt‐Jakob disease
Muhleisen, H., Gehrmann, J., & Meyermann, R. (1995) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1995.tb01097.x · Cited by 98
Xu, X., Yang, D., Wyss‐Coray, T., Yan, J. S., Gan, L., Sun, Y. N., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7547 · Cited by 95 · cited 1×
“Similar anti-apoptotic activities have been reported for APP and α-synuclein in vitro”
BackgroundInterventional strategies against prion diseases
Aguzzi, A., Glatzel, M., Montrasio, F., Prinz, M., & Heppner, F. L. (2001) · Nature reviews. Neuroscience · doi:10.1038/35094590 · Cited by 83 · cited 1×
“pl?P09813">apolipoprotein E , amyloid P-component and proteoglycans) have been reported to prevent protein aggregatio”
BackgroundSmall is not beautiful: antagonizing functions for the prion protein PrPC and its homologue Dpl
Behrens, A., & Aguzzi, A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02089-0 · Cited by 78
Mice Deficient for the Amyloid Precursor Protein Gene
Zheng, H., Jiang, M., Trumbauer, M. E., Hopkins, R., SIRINATHSINGHJI, D. J. S., Stevens, K. A., Conner, M. W., Slunt, H. H., Sisodia, S. S., Chen, H. Y., et al. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34456.x · Cited by 74 · cited 1×
“However, APP and α-synuclein knockout mice show no signs of neurodegeneratio”
BackgroundComparative Stability and Clearance of [Met30]Transthyretin and [Met119]Transthyretin
Longo Alves, I., Hays, M. T., & Saraiva, M. J. M. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00662.x · Cited by 73
Coelho, T., Chorão, R., Sousa, A., Alves, I. L., Torres, M. F., & Saraiva, M. J. (1996) · Neuromuscular Disorders · doi:10.1016/0960-8966(96)88826-2 · Cited by 61 · cited 1×
“Heterozygote patients that have both the stabilizing T119M and pathogenic (V30M) mutations show slower disease progressio”
BackgroundThe Challenge of Inhibiting Aβ Polymerization
LeVine, H. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023370167 · Cited by 41
Neuron numbers in Alzheimer's disease: Cell-specific pathology
Hyman, B. T., & Hoesen, G. W. V. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90133-3 · Cited by 12 · cited 1×
“Neuronal death in AD occurs mainly in regions of the brain that are implicated in memory and abstract thinking, such as the hippocampus, amygdala, entorhinal cortex and association areas of the neocorte”
Background
Cited by
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
Huang, Y., Ren, J., & Qu, X. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00672 · Cited by 3,523
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
The Alzheimer's Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.008 · Cited by 1,525
“It is characterized by accumulations of b-amyloid plaques and neurofibrillary tangles [2–6], which exert direct and indirect neurotoxic effects by promoting oxidative stress [7,8] and inflammation.”
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233
“While he pathway of the neurofibrillary tangles is very precise, ie, tarts in the entorhinal cortex from where it progresses to he hippocampus, the limbic system, and finally to neocorical regions, the amyloid deposition seems to be more eterogeneous and random starting first in neocortical reions before it affects al…”
Metadata
- Authors
- Soto, C.
- Corresponding author
- Soto, Claudio
- ORCID
- Soto, Claudio
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 49-60
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2007157911
- Cited by
- 1,506
- References
- 154
- Citations by year
- 2026: 45 · 2025: 70 · 2024: 75 · 2023: 73 · 2022: 95 · 2021: 88 · 2020: 107 · 2019: 80 · 2018: 86 · 2017: 107 · 2016: 92 · 2015: 75 · 2014: 67 · 2013: 45 · 2012: 57
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- protein misfolding, neurodegenerative diseases, protein aggregation, protein accumulation, neuronal apoptosis, common pathogenic mechanisms, therapeutic target
- MeSH terms
- Animals, Brain, Brain Chemistry, Humans, Protein Folding, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.